vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Verisign (VRSN). Click either name above to swap in a different company.
Verisign is the larger business by last-quarter revenue ($425.3M vs $236.8M, roughly 1.8× CROSS COUNTRY HEALTHCARE INC). Verisign runs the higher net margin — 48.5% vs -35.0%, a 83.5% gap on every dollar of revenue. On growth, Verisign posted the faster year-over-year revenue change (7.6% vs -23.6%). Verisign produced more free cash flow last quarter ($285.1M vs $16.1M). Over the past eight quarters, Verisign's revenue compounded faster (5.2% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Verisign, Inc. is an American company based in Reston, Virginia, that operates a diverse array of network infrastructure, including two of the Internet's thirteen root nameservers, the authoritative registry for the .com, .net, and .name generic top-level domains and the .cc country-code top-level domains, and the back-end systems for the .jobs and .edu sponsored top-level domains.
CCRN vs VRSN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $425.3M |
| Net Profit | $-82.9M | $206.2M |
| Gross Margin | — | 88.5% |
| Operating Margin | -30.2% | 67.0% |
| Net Margin | -35.0% | 48.5% |
| Revenue YoY | -23.6% | 7.6% |
| Net Profit YoY | -2109.7% | 7.7% |
| EPS (diluted) | $-2.56 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $425.3M | ||
| Q3 25 | $250.1M | $419.1M | ||
| Q2 25 | $274.1M | $409.9M | ||
| Q1 25 | $293.4M | $402.3M | ||
| Q4 24 | $309.9M | $395.4M | ||
| Q3 24 | $315.1M | $390.6M | ||
| Q2 24 | $339.8M | $387.1M | ||
| Q1 24 | $379.2M | $384.3M |
| Q4 25 | $-82.9M | $206.2M | ||
| Q3 25 | $-4.8M | $212.8M | ||
| Q2 25 | $-6.7M | $207.4M | ||
| Q1 25 | $-490.0K | $199.3M | ||
| Q4 24 | $-3.8M | $191.5M | ||
| Q3 24 | $2.6M | $201.3M | ||
| Q2 24 | $-16.1M | $198.8M | ||
| Q1 24 | $2.7M | $194.1M |
| Q4 25 | — | 88.5% | ||
| Q3 25 | 20.4% | 88.4% | ||
| Q2 25 | 20.4% | 88.0% | ||
| Q1 25 | 20.0% | 87.7% | ||
| Q4 24 | — | 87.8% | ||
| Q3 24 | 20.4% | 88.0% | ||
| Q2 24 | 20.8% | 87.8% | ||
| Q1 24 | 20.4% | 87.2% |
| Q4 25 | -30.2% | 67.0% | ||
| Q3 25 | -2.4% | 67.8% | ||
| Q2 25 | -2.1% | 68.5% | ||
| Q1 25 | -0.3% | 67.4% | ||
| Q4 24 | -1.1% | 66.7% | ||
| Q3 24 | 0.9% | 68.9% | ||
| Q2 24 | -5.7% | 68.8% | ||
| Q1 24 | 0.8% | 67.4% |
| Q4 25 | -35.0% | 48.5% | ||
| Q3 25 | -1.9% | 50.8% | ||
| Q2 25 | -2.4% | 50.6% | ||
| Q1 25 | -0.2% | 49.5% | ||
| Q4 24 | -1.2% | 48.4% | ||
| Q3 24 | 0.8% | 51.5% | ||
| Q2 24 | -4.7% | 51.4% | ||
| Q1 24 | 0.7% | 50.5% |
| Q4 25 | $-2.56 | — | ||
| Q3 25 | $-0.15 | — | ||
| Q2 25 | $-0.20 | — | ||
| Q1 25 | $-0.02 | — | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | $0.08 | — | ||
| Q2 24 | $-0.47 | — | ||
| Q1 24 | $0.08 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $580.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $-2.2B |
| Total Assets | $449.0M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $580.5M | ||
| Q3 25 | $99.1M | $617.7M | ||
| Q2 25 | $81.2M | $593.8M | ||
| Q1 25 | $80.7M | $648.5M | ||
| Q4 24 | $81.6M | $599.9M | ||
| Q3 24 | $64.0M | $644.9M | ||
| Q2 24 | $69.6M | $689.9M | ||
| Q1 24 | $5.2M | $924.7M |
| Q4 25 | $322.8M | $-2.2B | ||
| Q3 25 | $408.1M | $-2.1B | ||
| Q2 25 | $412.2M | $-2.0B | ||
| Q1 25 | $418.2M | $-2.0B | ||
| Q4 24 | $419.0M | $-2.0B | ||
| Q3 24 | $424.7M | $-1.9B | ||
| Q2 24 | $433.3M | $-1.8B | ||
| Q1 24 | $462.4M | $-1.6B |
| Q4 25 | $449.0M | $1.3B | ||
| Q3 25 | $538.2M | $1.4B | ||
| Q2 25 | $553.8M | $1.4B | ||
| Q1 25 | $576.2M | $1.4B | ||
| Q4 24 | $589.3M | $1.4B | ||
| Q3 24 | $597.4M | $1.5B | ||
| Q2 24 | $602.9M | $1.5B | ||
| Q1 24 | $648.4M | $1.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $289.6M |
| Free Cash FlowOCF − Capex | $16.1M | $285.1M |
| FCF MarginFCF / Revenue | 6.8% | 67.0% |
| Capex IntensityCapex / Revenue | 0.9% | 1.1% |
| Cash ConversionOCF / Net Profit | — | 1.40× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $1.1B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $289.6M | ||
| Q3 25 | $20.1M | $307.7M | ||
| Q2 25 | $4.2M | $202.5M | ||
| Q1 25 | $5.7M | $291.3M | ||
| Q4 24 | $24.2M | $231.5M | ||
| Q3 24 | $7.5M | $253.4M | ||
| Q2 24 | $82.4M | $160.4M | ||
| Q1 24 | $6.0M | $257.3M |
| Q4 25 | $16.1M | $285.1M | ||
| Q3 25 | $17.9M | $303.0M | ||
| Q2 25 | $2.3M | $194.7M | ||
| Q1 25 | $3.8M | $285.5M | ||
| Q4 24 | $21.7M | $222.0M | ||
| Q3 24 | $6.3M | $247.8M | ||
| Q2 24 | $79.6M | $151.2M | ||
| Q1 24 | $3.8M | $253.5M |
| Q4 25 | 6.8% | 67.0% | ||
| Q3 25 | 7.2% | 72.3% | ||
| Q2 25 | 0.8% | 47.5% | ||
| Q1 25 | 1.3% | 71.0% | ||
| Q4 24 | 7.0% | 56.1% | ||
| Q3 24 | 2.0% | 63.4% | ||
| Q2 24 | 23.4% | 39.1% | ||
| Q1 24 | 1.0% | 66.0% |
| Q4 25 | 0.9% | 1.1% | ||
| Q3 25 | 0.9% | 1.1% | ||
| Q2 25 | 0.7% | 1.9% | ||
| Q1 25 | 0.6% | 1.4% | ||
| Q4 24 | 0.8% | 2.4% | ||
| Q3 24 | 0.4% | 1.4% | ||
| Q2 24 | 0.8% | 2.4% | ||
| Q1 24 | 0.6% | 1.0% |
| Q4 25 | — | 1.40× | ||
| Q3 25 | — | 1.45× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | — | 1.46× | ||
| Q4 24 | — | 1.21× | ||
| Q3 24 | 2.92× | 1.26× | ||
| Q2 24 | — | 0.81× | ||
| Q1 24 | 2.23× | 1.33× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
VRSN
Segment breakdown not available.
